Kim et al. conducted an attractive study of drug-loaded liposomes linked with two DNA aptamers that targeted the surface marker transmembrane glycoprotein MUC1 on breast cancer cells and the surface glycoprotein CD44 antigen on breast cancer stem cells (CSCs). The gene discussed is CD44; the disease is breast cancer.